Gemcitabina en 4 pacientes con colangiocarcinoma / Gemcitabine in the treatment of cholangiocarcinoma: report of 4 cases
Rev. méd. Chile
;
129(8): 911-916, ago. 2001. ilus, tab
Artigo
em Espanhol
| LILACS
| ID: lil-300152
ABSTRACT
Cholangiocarcinoma is a biliary tree cancer of unknown etiology, whose symptoms are unspecific and is usually detected in advanced stages. Surgery continues to be the only curative therapy. Median survival in patients with inoperable tumors ranges between 5 and 8 months. There are few studies on the effects of chemotherapy, with a very small response. We report four patients with advanced cholangiocarcinoma, treated with gemcitabine 1000 mg/m2, weekly for 3 weeks every 28 days. There was a stabilization of tumor size and symptoms were alleviated. Toxicity was low and there was a probable prolongation of survival
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Neoplasias dos Ductos Biliares
/
Colangiocarcinoma
/
Desoxicitidina
/
Antineoplásicos
Limite:
Humanos
/
Masculino
Idioma:
Espanhol
Revista:
Rev. méd. Chile
Assunto da revista:
Medicina
Ano de publicação:
2001
Tipo de documento:
Artigo
País de afiliação:
Chile
Instituição/País de afiliação:
Universidad de Chile/CL
Similares
MEDLINE
...
LILACS
LIS